First Phosphate Closes Follow-on Tranche of Oversubscribed Private Placement
Executive Summary
- First Phosphate Corp. closed a subsequent tranche of its non‑brokered private placement, raising $1,390,699 from the issuance of 1,111,110 Flow‑Through Shares and 431,111 Hard Dollar Units (including common shares and warrants).
- Cumulatively, the company has now raised approximately $43.6 million across ten management‑led non‑brokered private placements since June 2022.
- The Company also granted 4.7 million incentive stock options and 1.303 million restricted stock units to officers, directors and eligible participants under its Omnibus Equity Incentive Plan.
Key Details
- Tranche 2 Financing (Nov 21 2025):
- Flow‑Through Shares: 1,111,110 shares at a deemed price of $0.90 per share → $999,999 gross proceeds.
- Hard Dollar Units: 431,111 units consisting of:
- 431,111 common shares (price $0.90) → $390,700 gross proceeds.
- 431,111 warrants exercisable at $1.25 per share (expiry Apr 30 2026, accelerated expiry date).
-
Total Raised in Tranche 2: $1,390,699.
-
Overall Offering Summary (both tranches):
- Flow‑Through Shares: 3,355,832 shares → $3,020,249 gross proceeds.
- Hard Dollar Units: 611,777 units → $550,560 gross proceeds.
-
Combined Gross Proceeds (both tranches): $3,570,848.
-
Cumulative Private‑Placement Funding Since June 2022: Approximately $43.6 million across ten management‑led financings.
-
Compensation Shares & Warrants Issued with Tranche 2:
- 88,888 compensation common shares at $0.90 per share.
-
88,888 compensation warrants exercisable at $1.25 per share (expiry Apr 30 2026, accelerated expiry date).
-
Corporate Finance Fee Paid: $12,500.
-
Statutory Hold Period: All securities issued are subject to a four‑month plus one‑day hold period under applicable securities laws.
-
Use of Proceeds: As disclosed in the Company’s November 7 2025 press release (intended for project development, working capital, and general corporate purposes).
-
Equity Incentive Grants (RSU & Options):
- Incentive Stock Options: 4,700,000 options at $0.90 exercise price; expire Dec 29 2028; vest 25 % every six months over two years from grant date.
- Restricted Stock Units: 1,303,000 RSUs; vest on Jan 1 2026.
-
All option and RSU securities also subject to the four‑month plus one‑day statutory hold period.
-
Future Financing Flexibility: Company may close additional tranches of the Offering at its discretion.
Notable Quotes
(No direct quotes were provided in the release.)